Fig. 3From: High IRF8 expression correlates with CD8 T cell infiltration and is a predictive biomarker of therapy response in ER-negative breast cancerIRF8 is a prognostic marker in breast cancer ER-negative cancer. Kaplan-Meier plots of overall survival (OS) and relapse-free survival (RFS) by IRF8 status within molecular subtype BC. IRF8 groups were stratified using median cutoff of IRF8 value. The relationship between IRF8 expression and BC patients OS (a) and RFS (b) was analyzed using the Kaplan-Meier plotter data base (http://kmplot.com/analysis/). c) RFS was compared between high- and low-IRF8-expressing breast tumors for grade 1, grade 2, and grade 3 tumors. ER+: G1 (n = 323), G2 (n = 820), G3 (n = 492); ER−: G1 (n = 22), G2 (n = 81), G3 (n = 411). Patient samples were grouped based on the expression of IRF8 using the median cutoff valueBack to article page